A significant level of correction of the mutation responsible for sickle cell anemia has been achieved in monkey COS-7 cells on a plasmid containing a b-globin gene fragment. The plasmid was treated in vitro with a nucleic acid 'third strand' bearing a terminal photoreactive psoralen moiety that binds immediately adjacent to the mutant base pair. Following covalent attachment of the psoralen by monoadduct or diadduct formation to the mutant T-residue on the coding strand, the treated plasmid was transfected into the cells, which were then incubated for 48 h to allow the cellular DNA repair mechanisms to remove the photoadducts. Upon reisolation and amplification of the transfected plasmid, sickle cell mutation correction, as determined by sequence analysis of both complementary strands, was established in a full 1%. This result encourages extension of the approach to correct the mutation directly on the chromosome.
Introduction
The prevailing approach to gene therapy for diseases due to point mutations has been to try to add the wild-type antecedent of the mutant gene using a viral vector that integrates into the genome. [1] [2] [3] While this type of scheme is intrinsically reasonable, the results of such efforts have been fraught with problems because of the difficulty in assuring integration of the replacement gene at the correct chromosomal site and its long term expression. This is particularly the case when the regulation of a gene is complex. Hence, the prospect for correcting a point mutation directly in the endogenous gene on the chromosome is very attractive. Previous attempts to do so have been made using 'chimeraplasty', that takes advantage of cellular mismatch repair coupled to homologous recombination using chimeric RNA-DNA strands. [4] [5] [6] [7] However, the resultant frequency of mutation correction has been highly variable; 8, 9 more consistent results were obtained when deoxyoligonucleotides instead of chimeric strands were used to induce sitespecific base changes. 10 We have been exploring an alternative approach to correct a mutant base pair directly on the chromosome. This approach uses selective chemical modification of the mutant base pair to trigger error prone DNA repair mechanisms that tend in some cases to insert the desired wild-type base pair. [11] [12] [13] [14] [15] The demonstration target we selected for this approach is the mutation responsible for sickle cell anemia, a heritable hematological disease which results from an A ÁT-T ÁA transversion in the sixth codon of the b-globin gene. This transversion changes a GAG codon to GTG, resulting in a single amino-acid change from Glu to Val. 16 The resultant enhanced hydrophobicity on the protein surface leads to hemoglobin polymerization that alters red cell shape, with many pathological consequences including chronic hemolytic anemia and painful vasoocclusive events. As the presence of only one sickle cell allele does not cause severe disease pathology, yet confers resistance to malaria, the mutation has become widespread wherever malaria is prevalent. 17 In order to revert this mutation, we designed a methodology for selectively modifying the mutant T residue with psoralen delivered to the mutation site by a deoxyoligonucleotide which binds with extremely high specificity immediately downstream from the mutation site by a combination of third strand-binding via triple helix formation and strand invasion via complementary base pairing. 18, 19 With an upstream 3 0 -end which is covalently linked by a deliberately short linker to a photoreactive intercalating psoralen moiety, the third strand binds via triplex formation to the first seven purine residues of the target duplex in the antiparallel G/T motif; 20 it then switches to the parallel C/T motif 21 to bind to the purine-rich residue sequence in the other strand of the target duplex; finally, it forms six complementary base pairs with one of the two duplex strands, displacing the other by strand invasion.
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( Figure 1 ). The uniqueness of the b-globin gene target in the human genome was confirmed by a careful sequence search. Moreover, the specificity of the psoralen delivery strand for that target is consistent with what is known of the inherent great specificity of third strandbinding. [23] [24] [25] Upon irradiation, the photoreactive psoralen moiety forms a photoadduct to the mutant T residue in the coding strand ( Figure 2) . 18, 19, 26, 27 The psoralen photoadduct is recognized as DNA damage and is removed by the DNA repair mechanisms of the cell, which often replace the psoralen-T adduct with an A residue, resulting in the desired mutation correction. 12, 14 To explore the feasibility of the triplex-mediated approach for the desired mutation correction, experiments were undertaken under tractable circumstances with a plasmid bearing a fragment of the sickle cell b-globin gene sequence ( Figure 3) . A plasmid photomodified in vitro and purified from nonmodified plasmid before transfection was used for this purpose. Thus, only photomodified plasmid was transfected into cells. Consequently, only plasmid whose psoralen photoadducts were removed by the DNA repair machinery could be replicated. In this way, the maximum repair potential of directed psoralen modification was evaluated. The presence of any nonphotomodified plasmid would obscure the true repair potential inherent in the cells. In what follows, we describe the binding of the psoralendelivery strand to the plasmid in vitro, and the significant level of mutation correction that occurs in vivo when the treated plasmid is transfected into COS-7 cells.
Results

Plasmid target design
The sickle cell b-globin target duplex ( Figure 1 ) was inserted into a shuttle vector pEGFP-N1 (Clontech, Palo Alto, CA, USA) capable of replication in both mammalian and bacterial cells. To enable separation of plasmid with covalently bound delivery strand from unmodified plasmid, a unique BaeI recognition site overlapping the delivery strand target sequence was created by inserting an extra six base pair sequence upstream of the b-globin sickle cell gene target. BaeI can cleave both strands of the plasmid DNA upstream and downstream of its recognition sequence [(10/15)ACNNNNGTAYC(12/7)] 28 ( Figure 1 ). The delivery strand directs the psoralen moiety to form a photoadduct (either monoadduct or a crosslink with the sickle cell mutant T residue (Figure 2 ). The UVA (365 nm) and visible light (419 nm) irradiation protocols employed in this work 27 were designed and tested on a linear model system, 18, 19 and the photoproduct yield and variety were similar for the plasmid system. Thus, the UV irradiation protocol leads predominantly to formation of both monoadducts to the mutant T residue (35% Figure 1 Interaction of the psoralen delivery strand (solid dashes connect its residues) with the target sequence immediately downstream of the sickle cell mutation in the b-globin gene. The psoralen moiety that modifies the mutant T residue is linked to the 3 0 end of the delivery strand. The dots indicate the hydrogen bonds of the duplex base pairs, while the slanted dashes represent hydrogen bonds between the delivery strand bases and the target bases in the duplex. Figure 2 Major photoproducts formed by psoralen upon irradiation of the bound delivery strand. The principal psoralen monoadduct (MA) that forms both upon UVA and visible light irradiation is indicated by a rectangle, while the only crosslink (XL, only formed upon UVA irradiation) observed is shown by the shaded ellipse. Figure 3 The plasmid with the sickle cell b-globin insert showing the DdeI, BaeI and BanI restriction sites. The sickle cell target is indicated by the diagonals. The bound psoralen delivery strand, indicated in gray, blocks the BaeI recognition site, preventing linearization of the plasmid by this restriction enzyme. An additional DdeI site is generated when the sickle cell mutation is corrected.
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Y Varganov et al of the total photoproducts) and crosslinks between this T residue and one of the C residues on the opposite strand (45% of the total photoproducts); minor quantities of other photoproducts, at a T residue of the previous codon (o5%) and at C residues on the opposite strand (o5%) also form. 19 In contrast, visible light irradiation results in monoadduct formation exclusively; no crosslinks are formed. 27 The mutant T residue is in the first base pair of the unique BaeI recognition site; covalent binding of the delivery strand to this residue and downstream of the BaeI recognition site prevents BaeI endonuclease from cleaving the plasmid (Figure 3) . Hence, plasmids with covalently bound delivery strand cannot be linearized by BaeI and remain supercoiled; they are separated from unmodified plasmids by agarose gel electrophoresis as they migrate faster than the linearized plasmid. In fact, the supercoiled plasmid resistant to BaeI cleavage was shown by bandshift assay to be almost fully (98% in different experiments) photomodified ( Figure 4 ). This plasmid population was used for transfection.
Delivery strand binding to the plasmid and photoproduct yield
Delivery strand binding and psoralen photoproduct formation was monitored by bandshift of a 252 bp BanI restriction fragment containing the target (see Figure 4) . To enable quantitation, this fragment was labeled with DNA polymerase, which fills the recessed (sticky) end of the duplex without modifying the exposed 5 0 -end of the delivery strand. K d for delivery strand binding to the plasmid is B300 nM. Polyethyleneglycol (PEG) was added to the plasmid/delivery strand mixture to mimic intracellular macromolecular crowding, 29 resulting in 80% photomodified plasmids compared to B55% without PEG.
Transfection of the photomodified plasmid into Monkey COS-7 cells
Monkey COS-7 cells were selected for these experiments because of the extensive knowledge of their ability to process third strand-directed psoralen photoadducts. [12] [13] [14] Thus, nucleotide excision repair has been shown to be responsible for repairing bulky DNA adducts. Psoraleninduced mutagenesis has also been found to depend on whether the photoproduct is a monoadduct or a crosslink and even on the size of the psoralen-delivery strand. 11, 12, 30, 31 Bound but not covalently attached third strands are also recognized as DNA damage and are mutagenic in these cells. 32 Particularly appropriate for our effort to correct the sickle cell A ÁT-T ÁA transversion, psoralen adducts at T residues preferentially induce T ÁA-A ÁT transversions. 13, 14 It is important to note, however, that the foregoing observations were made using a simple homopurine strand with the psoralenlinked to its 5 0 -end. In the present work with the sickle cell target, we designed a complex delivery strand that binds to alternate strands of the target duplex in two different motifs (first G/T antiparallel and then pyrimidine/parallel), followed by a strand-invading element; in this case the psoralen is linked to the 3 0 -terminus. 18 Transfection conditions and plasmid expression COS-7 cells were transfected with DNA photoproducts using Tfx20 transfection reagent (Promega) and the Promega protocol for transfection of adherent cells. Based upon the amount of plasmid DNA, the plasmid transfection efficiency determined by flow cytometry, and the number of cells used for transfection, it is estimated that there are B10 5 plasmid copies per cell, which is consistent with other data on transfection of mammalian cells with GFP-expressing vectors. 33 The same plasmid subjected to the same irradiation and purification steps in the absence of the psoralendelivery strand, was used as a control in all experiments.
It is noteworthy that delivery strand attachment results in a significant delay in GFP expression ( Figure  5 ). In addition, the eventual number of green cells was significantly less for the photomodified plasmid than for the control, which was transfected with the same amount of plasmid ( Figure 5 ). It seems unlikely that covalent binding of the delivery strand to the supercoiled plasmid should affect transfection efficiency, since delivery strand Sickle Cell mutation repair on a plasmid in COS-7 Y Varganov et al binding does not change plasmid conformation or alter its interaction with the transfection reagents. It is more reasonable to think that expression of plasmid-encoded GFP is delayed until psoralen damage is repaired.
Screening for correction of the sickle cell mutation
After replication in COS-7 cells, plasmid DNA was purified and used to transform Escherichia coli. Previously, 12, 14 DpnI digestion was used to eliminate unreplicated plasmid molecules prior to E. coli transformation. To evaluate the input from the residual unreplicated plasmid in our experiments, we transformed the photomodified plasmid into K562 cells, in which the pEGFP-N1 vector cannot be replicated. We, therefore, compared the number of E. coli transformants obtained after standard plasmid purification from transfected COS-7 and K-562 cells after 48 h of incubation. The plasmids reisolated from K562 cells yielded less than five clones, whereas the same quantity of plasmid transfected into COS-7 cells and reisolated generally gave 200-500 E. coli transformants. For this reason, the potential input from unreplicated plasmids was considered negligible, and the DpnI digestion step was omitted.
As correction of the sickle cell mutation results in a new DdeI restriction site (Figure 6a ), a DdeI restriction analysis was used as an initial screening for mutation correction. This assay was employed after plasmid DNA was replicated in the COS-7 cells, amplified in E. coli and then purified from bacterial clones. The assay depends upon a reduction in the size of one of the existing fragments. As DdeI has another restriction site 28 bp upstream from the mutation site, the same assay also serves to indicate whether any large deletions or translocations have occurred in the region surrounding the mutation (Figure 6b) .
Frequency of psoralen adduct-induced correction of the sickle cell mutation
In each experiment, we first screened plasmid DNA from B200 clones using the DdeI restriction assay. Clones displaying faster mobility of the target DdeI fragment (indicative of sickle cell mutation correction) were further analyzed by sequencing in both directions using primers at residues 426 on one strand and 822 on the other (the target is located between residues 634 and 670). It is important to note that in addition to the desired T-A transversion at the sickle cell mutation site, other changes in the DdeI restriction patterns were sometimes observed (Figure 6b ), presumably indicative of additional mutagenesis as a consequence of covalent attachment of the delivery strand.
The cumulative results of two types of experiments, one with UV irradiation and the other with visible light irradiation, are given in Table 1 . Plasmid without an attached delivery strand that otherwise underwent the same experimental steps (irradiation, supercoiled plasmid purification by gel-electrophoresis and transfection) served as one control. When the control plasmid was UVirradiated for the required 20 min, a 3.4% background rate of nonspecific mutagenesis was observed. In contrast, after the required 4 h of visible light irradiation, no mutations were detected. This difference is consistent with the known mutagenicity of UV irradiation of DNA, which results in error-prone repair of T-T dimers of various types. 34 As an additional control, plasmids with covalently attached delivery strand were transformed directly in E. coli in order to establish that the E. coli amplification step does not contribute to the overall mutagenesis or mutation correction. In fact, no mutation correction or any other sequence changes were detected. This lack of mutagenesis in the E. coli control is consistent with what is known about the processing of psoralen adducts in bacterial cells, that is, that activation of SOS-repair by UV-irradiation is crucial for psoralen photoadduct Figure 6 Screening assay for mutation correction and other mutational events based on DdeI digestion. (a) Mutation correction results in an additional DdeI restriction site and leads to shortening of the corresponding restriction fragment from 679 to 651 bp, and therefore an increase in its mobility. (b) DdeI digestion patterns observed for the sickle cell mutation (SC), after its correction (W) and for other mutational events (M). Other restriction enzyme digests (BanI, HaeIII -not shown) display mutant restriction patterns only in the same clones as DdeI, suggesting that DdeI screening is comprehensive. Sickle Cell mutation repair on a plasmid in COS-7 Y Varganov et al removal. 35 As the E. coli were not irradiated, the clones obtained after E. coli transformation with photoadductcontaining plasmid most probably result from the trace amount of unmodified plasmid. More important, this result shows that all the observed mutation correction occurs in the COS-7 cells.
Against these controls, a total of six clones were found in which the sickle cell mutation was corrected without any other changes in the plasmid sequence, that is, 1%; three in 273 clones after UV-irradiation and three in 328 after irradiation with visible light. Covalent binding of the delivery strand by irradiation also leads to other types of mutations, including deletions around the mutation site and long-range translocations. In all, 9.9% of such mutations were observed after UV, and 15.5% after visible light irradiation. This level of cumulative mutation induction is much higher than the rate observed for psoralen-triggered triplex-mediated mutagenesis in COS-7 cells previously reported, 12, 14, 32 o1% and B5% for visible light and UV irradiation, respectively. It is also B1000-fold higher than the rate of mutation induced by noncovalently attached triplexes. 32 Interestingly, whereas mutation correction was essentially the same by both irradiation protocols, the fraction of undirected mutations was surprisingly greater with visible than with UV light. Both monoadducts and crosslinks greatly stabilize the triplex (by converting the duplex-third strand interaction from a bimolecular into a unimolecular one). However, while monoadduct formation should not prevent duplex strand separation, crosslink formation does; therefore, it is possible that different DNA repair mechanisms are activated to deal with the two types of damage, and the degree to which they are error-prone may differ.
There are several possible explanations for the differences between the results presented here and those reported by others. One explanation for our generally higher mutation rate, including mutation correction, may be our careful purification of the plasmids bearing the covalently attached delivery strand. In fact, the numbers reported here represent a direct measure of the frequency of errors introduced by the DNA repair system when correcting DNA damage in the form of psoralen photoproducts. Obviously, the presence of unmodified plasmids would reduce the true proportion of induced mutations. Alternatively, overall higher mutagenesis that includes many long-range mutational events could be the result of our delivery strand design in which its third strand binding component hydrogen bonds first to one, then to the other strand of the duplex and so serves as a 'clamp' that prevents the strand unwinding essential for adequate functioning of the DNA repair enzymes. In contrast, most previous studies used third strands that are directed to residues on only one strand of the target duplex. In addition, whereas our screen recognizes mutations throughout the plasmid, the screen employed by Glazer et al., for example, was limited to changes in the Sup F gene component of their construct. 12, 14, 32 
Discussion
We here have demonstrated relatively efficient correction of the sickle cell mutation using the endogenous cellular DNA repair machinery activated by site-specific DNA damage inflicted on the mutant T residue in a plasmid by psoralen brought there by a highly sequence-specific deoxyoligonucleotide delivery strand. The specificity of that delivery is determined by an uncommon combination of third strand-binding elements and a strandinvading one, which together fix the site of psoralen delivery. Photoadducts of the delivery strand were formed on the plasmid in vitro, and the resultant modified plasmid was transfected into cells so that the efficiency of such photomodification in vivo would not be a factor in determining the rate of mutation correction. In this way, the resultant correction could be unambiguously linked to the photoadduct formation. The 1% rate of correction achieved, as confirmed by sequencing, is much higher than in previous attempts to use psoralen photoproduct formation as a mutagen in the Sup F gene within a plasmid. 12, 14 It is also worth noting that the nonspecific mutagenesis we have found need not be a concern for the therapeutic application of our approach, since a selection step can be used to eliminate them. A level of 1% mutation correction coupled to such selection may therefore be considered of 'therapeutic efficiency'. This result encourages us to use the same delivery strand to achieve correction of the sickle cell mutation directly on the chromosome.
Materials and methods
Delivery strand binding to plasmid
Psoralen-delivery strand binding to the plasmid was performed in vitro in 0.1 M sodium acetate-pH 5.0/0.01 M magnesium acetate and 20% PEG 1000. Pre-warmed (651C, 5 min) delivery strand stock solution was added to plasmid maintained at 231C; final concentrations were 200 nM plasmid and 10 mM delivery strand, well above the K d value. Complexes were incubated overnight at 231C and then at 41C for 3 h, before irradiation either with UVA light (365 nm, 30 min) to mainly produce crosslinks or with visible light (419 nm, 4 h) to produce monoadducts exclusively. 27 The resultant covalent complexes were purified from free delivery strands using a Qiagen PCR purification kit.
Isolation of plasmid with covalently bound third strand
In order to separate photoproduct-containing DNA from unmodified plasmid, the irradiated mixture was digested by BaeI for 1 h at 201C, conditions that maximize digestion of unprotected restriction site while minimizing cleavage of photoproducts. Following restriction, the DNA was fractionated on 1% agarose gel (TBE, 75 V, 3 h). The band containing supercoiled photo-modified plasmid was excised from the gel, and a QIAquick Gel Purification kit (QIAGEN) was used to purify the plasmid.
Electrophoretic bandshift analysis of BanI digestion fragments showed that the DNA so isolated contained o2% of unmodified plasmid and was overwhelmingly supercoiled and therefore suitable for subsequent transfection into mammalian cells.
Transfection of COS-7 cells
Typically, the COS-7 cells were plated 24 h before transfection on six-well cell culture plates (Falcon), B2.5 Â 10 5 cells/well. At this density, cells are B80%
Sickle Cell mutation repair on a plasmid in COS-7 Y Varganov et al confluent on the day of transfection. Tfx20 (1.6 mg) was resuspended in 400 ml of nuclease-free water the day before transfection. For each well, 2-3 mg of plasmid DNA in o10 ml H 2 O was added to prewarmed to 371C DMEM (ATCC) Serum-free medium (0.9 ml/well) in a sterile tube and vortexed. Tfx20 reagent (4.5 ml for each mg DNA) was added, and the mixture was immediately vortexed. The reagent/DNA mixture was incubated for 10-15 min at 231C. The media was then removed from the cells and 0.9 ml/well of the reagent/DNA mixture in serum-free media was added.
Plates were incubated at 371C for 1 h, and then the cells were gently overlaid with complete cell culture medium containing FBS (2 ml/well) and returned to the 371C incubator. After 3-4 h, half the medium in the wells was carefully replaced with fresh medium to reduce the toxicity of the Tfx reagent. The next day, plates were checked for appearance of GFP in the cells. Cells were harvested 48 h after transfection. For harvesting, media was removed from the wells, cells were gently rinsed with sterile PBS, trypsinized (0.25% trypsin with EDTA (Invitrogen) 371C, 10 min) and collected in a sterile tube. After centrifugation, the cell pellet was washed 3 times at 221C with sterile PBS, and then frozen at À201C in preparation for plasmid extraction.
Plasmid DNA recovery
Replicated plasmid was recovered from COS-7 cells using a Qiagen DNA purification kit and transformed by electroporation into E. coli DHa5 cells for clonal analysis.
